Scinai Immunotherapeutics Secures $5.1M in CDMO Work, Extends Runway to Late 2027
Scinai announced about $5.1 million in committed CDMO services and about $5.3 million in net financing proceeds. It estimates its operating runway will extend to late 2027, with potential extension into Q3 2028 if later project phases are activated.